Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The study, published today in The New England Journal of Medicine, involved researchers from Vall d'Hebron University Hospital.

The Vall d'Hebron University Hospital Research Institute demonstrates how there is a significant decrease in the secretion of inflammatory signals of the intestinal mucosa in Crohn's disease thanks to the presence of Lactobacillus casei.

VHIR researchers have discovered how abnormal protein clusters in nerve cells are associated with neuronal death in Parkinson's disease and propose a new experimental therapeutic strategy.

Levels of a protein called aprataxin are related to patient response to irinotecan, a drug used in the chemotherapy of patients with colon cancer.

Cristina Garmendia highlighted the importance of the transfer from the Instituto Carlos III to her department to increase the multidisciplinary nature of medical R&D.

Between 60 and 70% of children with attention deficit hyperactivity disorder (ADHD) continue to suffer from the disorder when they become adults.

This global classification allows researchers to define, in their search, the number of variables that may be implicated in disease, moving closer correlation between the state of the intestinal flora and the health of the individual.

The pessary is a simple silicone ring, inexpensive (38 euros), non-invasive and easy to insert and remove. It is inserted vaginally around the cervix without surgical intervention. 95% of women who have carried it would recommend it to other pregnant women at risk.

This work has identifyed four genes related to the predisposition to present the most frequent type of migraine: MEF2D, TGFBR2, PHACTR1 and ASTN2.

Phospholipase is a marker with enormous potential: risk of stroke, risk of recurrence, response to treatment and prognosis. Until now, there has been no such complete biomarker.

The study determines that the exposure of occult avian antigens from feather bedding is one of the main causes

With the new status the Institute will launch the Master Degree in Translational Biomedical Research

The finding opens the door to the development of a program to determine the severity and focus the treatment

The two commercial available genotyping methods can only identify a few subtypes of the disease

The research, carried out by members from the PROSICS and VHIR, has revealed that 61% of school-age children in Cubal carry the eggs of the worm that causes this disease.

A study led by the Vall d'Hebron Research Institute (VHIR) concludes that Crohn's disease could be diagnosed by determination of 8 microbial biomarkers. More than 2,000 stool samples of European patients with Crohn's disease, ulcerative colitis, anorexia and healthy people have been analysed to identify biomarkers and validate of method.

The study has begun with the recruitment of the first five patients of the fifty who will be part of the study

The study, published in Science and in which Vall d'Hebron has participated, has deepened in the common genetic bases of 25 brain diseases.

A pioneering space to study the brain of patients with migration that will attend more than 8,000 people a year and that also aims to empower patients to become their own prescribers.

The biggest profit generated by a State Research Institute for a patent and it will be entirely reinvested in the VHIR's research.

In record time and with our own resources, we have been able to develop the massive sequencing methodology to obtain the complete genome of the SARS-CoV-2 virus and from now on be able to do it in more patients.

Researchers have found lung-resident memory T lymphocytes months after SARS-CoV-2 infection, which would rapidly activate in the event of possible reinfection.

Today, 30 November, the main research lines in which both institutions will be working together are revealed.

The technique developed at Vall d'Hebron Research Institute (VHIR) uses a "switch" to block the reproduction of neuroblastoma cells